Since 1953, the National Pharmaceutical Council (NPC) has sponsored and conducted scientific, evidence-based analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. Over the years, breakthroughs in medical treatment through pharmaceuticals have largely improved patient care, but the increased use of pharmaceuticals has also resulted in questions about appropriate use and spending of health care dollars.
Based in Reston, Virginia, NPC supports numerous educational and research ventures advancing the appropriate use of pharmaceuticals for the betterment of human health. Sharing in its vision of demonstrating that pharmaceuticals, when used properly, can improve both patient treatment outcomes and the cost effective delivery of overall health care services, the NPC is supported by more than 20 research-based member companies.
The NPC communicates the economic, clinical and societal value of pharmaceuticals to a variety of health care stakeholders, including patients, clinicians, payers and policy makers through a strategy that includes the development of a wide breadth of intellectual assets, partnerships with member companies and outside organizations, and the dissemination of informative programs and products.
